Ubs Group Ag Kronos Bio, Inc. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,012 shares of KRON stock, worth $2,052. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,012Holding current value
$2,052% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding KRON
# of Institutions
55Shares Held
18.9MCall Options Held
9.3KPut Options Held
100-
Vida Ventures Advisors, LLC2.77MShares$2.82 Million3.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.96 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.72MShares$1.75 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.47 Million0.1% of portfolio
-
Acadian Asset Management LLC Boston, MA1.3MShares$1.33 Million0.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $57.9M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...